|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Additional conditions recognized in this trial | ||||
| Arteriovenous Malformations | |||||
| Congenital Abnormalities | |||||
| 2 | More general conditions related to this trial | ||||
| Cardiovascular Abnormalities | |||||
| Cardiovascular Diseases | |||||
| Vascular Diseases | |||||
| Vascular Malformations | |||||
| 3 | Sponsors listed in this trial | ||||
| Columbia University | |||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||